The Batch No. H29 of Artificial Eye Ointment, distributed by Delsam Pharma, is pictured in a provided photo. (Credit: FDA / Global Pharma Healthcare) WASHINGTON - A company that previously recalled over-the-counter eye drops linked to an outbreak of drug-resistant infections recently expanded notice to include its eye ointment cream.The U.S.
Food and Drug Administration announced the expanded recall of Global Pharma Healthcare’s Artificial Eye Ointment – distributed under the brand name Delsam Pharma – due to possible microbial contamination.
Using certain batches of the recalled product could result in an eye infection "that could lead to blindness," the FDA said in a Feb.
24 notice. The agency added that some packaging of the recalled product is also leaking or may otherwise be compromised.The Artificial Eye Ointment (mineral oil 15%, white petrolatum 83%, 3.5 grams / 1/8 oz.) is used as an eye lubricant and to relieve dryness, the FDA notice states.